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ABSTRACT Mammalian Ecdysoneless (ECD) is a highly conserved ortholog of the
Drosophila Ecd gene product whose mutations impair the synthesis of Ecdysone and
produce cell-autonomous survival defects, but the mechanisms by which ECD func-
tions are largely unknown. Here we present evidence that ECD regulates the endo-
plasmic reticulum (ER) stress response. ER stress induction led to a reduced ECD pro-
tein level, but this effect was not seen in PKR-like ER kinase knockout (PERK-KO) or
phosphodeﬁcient eukaryotic translation initiation factor 2 (eIF2) mouse embryonic
ﬁbroblasts (MEFs); moreover, ECD mRNA levels were increased, suggesting impaired
ECD translation as the mechanism for reduced protein levels. ECD colocalizes and
coimmunoprecipitates with PERK and GRP78. ECD depletion increased the levels of
both phospho-PERK (p-PERK) and p-eIF2, and these effects were enhanced upon ER
stress induction. Reciprocally, overexpression of ECD led to marked decreases in
p-PERK, p-eIF2, and ATF4 levels but robust increases in GRP78 protein levels. How-
ever, GRP78 mRNA levels were unchanged, suggesting a posttranscriptional event.
Knockdown of GRP78 reversed the attenuating effect of ECD overexpression on
PERK signaling. Signiﬁcantly, overexpression of ECD provided a survival advantage to
cells upon ER stress induction. Taken together, our data demonstrate that ECD pro-
motes survival upon ER stress by increasing GRP78 protein levels to enhance the
adaptive folding protein in the ER to attenuate PERK signaling.
KEYWORDS ECD, ER, PERK, UPR, cell survival, GRP78
The endoplasmic reticulum (ER) is a central subcellular organelle with essential rolesin the synthesis, folding, and maturation of secreted and membrane proteins,
biogenesis of cholesterol, calcium homeostasis, and regulation of survival and apop-
tosis pathways (1–10). Aberrations in these ER functions are sensed by well-
conserved ER transmembrane sensors, namely, inositol-requiring enzyme 1 alpha
(IRE1), PKR-like ER kinase (PERK), and activating transcription factor 6 (ATF6), that
activate homeostatic signaling pathways collectively referred to as the unfolded
protein response (UPR) (11, 12). These ER stress sensors exhibit a dynamic and
reversible interaction with the ER chaperone GRP78 (13). In unstressed cells, GRP78
is bound to luminal domains of UPR sensors, which maintains them in an inactive
state (14). During ER stress, the increased load of unfolded proteins competes for
GRP78 binding, leading to activation of UPR sensors (15) which, through interme-
diate signaling, evokes overlapping as well as pathway-speciﬁc responses to restore
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ER homeostasis and promote cell survival or, alternatively, eliminate stressed cells
through apoptosis if homeostasis cannot be restored.
The PERK pathway has emerged as a key pathway in the cellular UPR as well as in
homeostasis under unstressed conditions and in disease states (16–21). Release of
GRP78 from PERK leads to its dimerization, autophosphorylation, and activation (15, 22,
23). A major PERK substrate is eukaryotic translation initiation factor 2 alpha (eIF2),
whose phosphorylation by PERK inactivates it, leading to a block in general cap-
dependent protein translation and a consequent decrease in the protein load entering
the ER (24); concurrently, PERK signaling selectively enhances the cap-independent
translation of speciﬁc mRNAs, such as that for activating transcription factor 4 (ATF4)
(24). ATF4 induces the expression of CCAAT/enhancer-binding protein-homologous
protein (CHOP), which promotes apoptosis in response to stress (24–32). PERK-induced
phosphorylation of eIF2 also inhibits cell cycle progression by reducing the levels of
cyclins, and hence cyclin-dependent kinase 2 (CDK2) activity (33–35). Termination of
PERK signaling together with dephosphorylation of eIF2 is required to reinitiate
protein synthesis and resume the cell cycle. Thus, the PERK-mediated UPR leads to a
coordinated program of cellular protection and mitigation of stress. However, PERK also
contributes to an alternate outcome through CHOP-mediated activation of a cellular
death pathway to eliminate severely damaged cells (24–32). Mechanisms to ﬁne-tune
the outcomes of UPR pathways are important to mitigate the negative consequences
of ER stress. This is of particular importance under conditions where cells experience ER
stress as part of their physiological responses, such as the case for antibody-secreting
plasma cells or insulin-secreting pancreatic islet cells (36). We have identiﬁed ECD as a
negative regulator of the PERK-mediated UPR.
The Ecd gene was ﬁrst identiﬁed based on genetic mutations in Drosophila that led
to reduced production of the developmentally regulated steroid hormone Ecdysone,
which is synthesized in the ER, hence the designation Ecdysoneless for such ﬂy mutants
(37). The mammalian Ecd gene was cloned based on the rescue of growth defects in a
Saccharomyces cerevisiae mutant with mutation of growth control regulatory gene 2
(GCR2), a glycolysis regulatory gene (38). Thus, the ECD protein was thought to be
involved in mammalian glycolysis gene expression and was initially named hSGT1
(human suppressor of gcr2) (38). We identiﬁed the same gene in a screen for interacting
partners of the human papillomavirus E6 oncoprotein and found it to interact with p53
and to transactivate p53-regulated genes (39, 40).
To elucidate the functional role(s) of mammalian ECD, we generated Ecd-null mice
and demonstrated that homozygous deletion of Ecd was early embryonic lethal, while
ex vivo Cre-mediated deletion of Ecd in Ecdﬂ/ﬂ mouse embryonic ﬁbroblasts (MEFs) led
to a proliferative block and a signiﬁcant decrease in cell survival (41, 42). ECD was found
to be essential for E2F target gene expression by facilitating the dissociation of the
retinoblastoma RB protein from E2F and promoting the G1 to S phase of cell cycle
progression (41). As a consequence, Ecd-null MEFs showed decreases in the levels of
cyclins A, B1, E, and D1 and a reduction in CDK2 kinase activity and were arrested in the
G1 phase of the cell cycle (41). Interestingly, E2F family proteins, such as E2F1, have
been implicated in UPR-mediated cell death (43). In addition to its promotion of G1/S
phase, ECD also promotes the G2/M phase of the cell cycle, and its knockdown induced
not just a G2/M arrest but also apoptosis (44). Induction of the UPR not only induces
apoptosis but also halts cell cycle progression in the G1 and G2 phases (33–35, 45), and
these effects are mediated by PERK (33, 34), suggesting a potential connection between
ECD and the PERK arm of the UPR.
More recently, we uncovered another mechanism by which ECD regulates cellular
proliferation, involving its interaction with the RUVBL1 and PIH1D1 components of the
prefoldin cochaperone R2TP (42), which is involved in the assembly or remodeling of
a number of protein and protein-RNA complexes to regulate many physiological
processes (46–52). Recently, it was reported that knockdown of the RUVBL1 component
of the R2TP complex induced a cell cycle block and ER stress (53). Furthermore, ECD has
been shown to associate with the stress response protein thioredoxin-interacting
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protein (TXNIP) (54), which is known to bind to the ER chaperone protein disulﬁde bond
isomerase (PDI) to increase its enzymatic activity to relieve ER stress (55). Lastly, TXNIP
was recently shown to be a novel component of the UPR and is regulated by the PERK
pathway (56). Thus, multiple lines of suggestive evidence pointed to a potential role of
ECD in the regulation of ER stress. In this study, we demonstrate that induction of ER
stress by use of both chemical ER stress inducers (thapsigargin and tunicamycin) and a
physiological ER stress inducer (glucose starvation) led to reduced ECD protein levels
and that this effect was not seen in PERK kinase domain knockout (PERK-KO) or
phosphodeﬁcient eIF2 MEFs. Notably, ECD mRNA levels were increased, suggesting
impaired ECD translation as a mechanism for reduced protein levels. Moreover, ECD
localizes and coimmunoprecipitates with the unfolded protein response mediators
PERK and GRP78. While ECD depletion increased the levels of phospho-PERK (p-PERK)
and its downstream targets, p-eIF2 and ATF4, ECD overexpression markedly decreased
their levels upon ER stress induction, whereas induction of the GRP78 protein robustly
increased, suggesting an enhanced adaptive folding capacity of the ER. Knockdown of
GRP78 reversed the attenuation of PERK signaling seen upon ECD overexpression.
Signiﬁcantly, ECD overexpression and depletion distinctly affected the survival out-
come of cells upon ER stress.
RESULTS
Induction of ER stress leads to reduced ECD protein expression in a PERK-
eIF2-dependent manner. To begin to explore the potential link of ECD to ER stress,
we asked if the levels of ECD protein are affected by the induction of ER stress. For this
purpose, the immortal human mammary epithelial cell line MCF-10A was treated with
thapsigargin or tunicamycin, two commonly used chemical ER stress inducers (57), and
ECD protein levels were analyzed by Western blotting. Treatment with both ER stress
inducers increased the level of p-eIF2, as expected (57) (Fig. 1A and B). Notably, a
concomitant time-dependent decrease in ECD protein levels was observed upon
treatment with either thapsigargin (Fig. 1A) or tunicamycin (Fig. 1B).
Given the effects of chemical ER stress inducers on ECD protein levels, we next
assessed whether physiological stresses, such as glucose starvation, would have similar
effects. For this purpose, we used the human pancreatic carcinoma cell line Panc-1,
which is known to exhibit ER stress upon glucose starvation (57). Signiﬁcantly, similar
to chemical ER stress, glucose starvation-induced ER stress also led to reduced levels of
ECD protein (Fig. 1C). To assess whether the decrease in ECD protein levels was due to
reduced ECD mRNA levels, we measured ECD mRNA levels by using real-time quanti-
tative PCR (qRT-PCR). Induction of CHOP mRNA was used as a control (Fig. 1D). Notably,
ECD mRNA levels not only were not reduced but in fact showed an increase (Fig. 1E),
suggesting that the reduction in ECD protein level was not at the transcriptional level;
likewise, physiological stress by glucose starvation also increased ECD mRNA levels (Fig.
1F). Since PERK activation and subsequent phosphorylation of eIF2 mediate a trans-
lational block in response to ER stress (24), we used MEFs in which this pathway is
genetically abrogated. First, we treated wild-type (WT) MEFs or MEFs from PERK-KO
mice (58) with thapsigargin and analyzed ECD protein levels by Western blotting. The
expected lack of PERK pathway activation in PERK-KO MEFs was conﬁrmed by a lack of
induction of PERK phosphorylation in PERK-KO MEFs compared to that in WT MEFs (Fig.
1G). Signiﬁcantly, while a decrease in ECD protein levels was observed in WT MEFs
treated with thapsigargin, the levels of ECD protein were unchanged in PERK-KO MEFs
(Fig. 1G). ECD mRNA was then assessed in PERK-KO and control MEFs to determine
whether the levels were altered upon thapsigargin treatment. Again, CHOP mRNA
induction was used as a positive control (Fig. 1H). As expected, in PERK-KO MEFs, CHOP
mRNA was very minimally induced upon thapsigargin treatment compared to that in
control cells (Fig. 1H), since CHOP is downstream of PERK (24–32). Notably, while ECD
mRNA increased in control WT MEFs, in PERK-KO MEFs, induction of ECD mRNA was low
compared to that in control WT MEFs (Fig. 1I).
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FIG 1 Induction of ER stress leads to reduced ECD protein expression in a PERK-eIF2-dependent manner. (A to C) MCF-10A cells were
treated with thapsigargin (Tg; 50 nM) (A) or tunicamycin (Tun; 50 ng/ml) (B), and Panc-1 cells were cultured in a glucose-free medium
(Continued on next page)
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To further examine the role of the PERK pathway in the downregulation of ECD
protein expression, we utilized MEFs from mice that carry a serine 51-to-alanine
mutation in eIF2, which prevents its phosphorylation by activated PERK and makes
the cells resistant to PERK-mediated translational blocking upon ER stress induction
(59). As expected, the levels of p-eIF2 increased in WT MEFs, but not in the phospho-
deﬁcient eIF2 mutant MEFs, when ER stress was induced with thapsigargin or tuni-
camycin (Fig. 1J, compare lanes 1 to 3 with lanes 4 to 6). Importantly, while ECD protein
levels decreased in WT MEFs treated with ER stress inducers (Fig. 1J, compare lane 1 to
lanes 2 and 3), the levels of ECD protein did not change in identically treated eIF2
mutant MEFs (Fig. 1J, compare lane 4 to lanes 5 and 6). Together, these results support
the conclusions that ECD protein levels are downregulated upon ER stress in a
PERK-eIF2-dependent manner and that ER stress upregulates ECD mRNA levels,
suggesting a regulatory link between ECD and the PERK pathway of ER stress.
ECD colocalizes and associates with PERK and GRP78. To further explore a potential
link between ECD and the ER stress pathway, we assessed the localization of ECD. We
ﬁrst performed immunoﬂuorescence by using superresolution structured illumination
microscopy (SIM), a technique that offers a much higher resolution than that with
conventional confocal microscopy (60, 61). Colocalization of PERK and GRP78 served as
a positive control, since PERK and GRP78 are known interacting partners (13). Indeed,
we observed that endogenous PERK and GRP78 were colocalized in a punctate distri-
bution (Fig. 2A). Signiﬁcantly, ECD also colocalized with PERK and GRP78 (Fig. 2B and
C), although not as extensively as the GRP78-PERK colocalization. Negative controls
(rabbit and mouse IgGs) showed no staining (Fig. 2D and E). Next, we performed
subcellular fractionation of MCF-10A cells to biochemically assess the ER localization of
ECD. This analysis showed the expected presence of ECD in the soluble fraction (40, 42).
Importantly, ECD was prominently present in the ER-containing microsomal fraction
(Fig. 2F). Given the colocalization of ECD with PERK and GRP78 (Fig. 2A to C), we
assessed if ECD associates with PERK and/or GRP78. First, we used PLA to assess the
proximity of ECD to GRP78 and PERK in MCF-10A cells. A known ECD interaction with
the PIH1D1 component of R2TP served as a positive control (42, 46). Indeed, ECD and
PIH1D1 formed distinct foci detectable by PLA (Fig. 2G, red dots). Signiﬁcantly, PLA
signals were also observed for ECD and GRP78 or ECD and PERK (Fig. 2H and I). Finally,
we carried out immunoprecipitation (IP) of ECD from lysates of MCF-10A cells, treated
or left untreated with thapsigargin, followed by Western blotting with PERK and GRP78
antibodies to assess their association. IP of ECD coimmunoprecipitated PIH1D1 (Fig. 2K),
as expected based on the known interaction of ECD with PIH1D1 (42, 46). Importantly,
PERK and GRP78 also coimmunoprecipitated with ECD (Fig. 2K, left panel). A reverse IP
of GRP78 also coimmunoprecipitated ECD with PERK used as a positive control (Fig. 2K,
right panel). Taken together, these results suggest that ECD associates with PERK and
GRP78.
ECD regulates the PERK arm of the UPR. The association of ECD with PERK and
GRP78 (Fig. 2) and the abrogation of the decrease in ECD levels in PERK-KO cells upon
ER stress (Fig. 1) suggested that ECD may be functionally linked to the UPR through the
PERK pathway. Therefore, we assessed the activation of the PERK pathway in the
absence or presence of UPR inducers in cells in which ECD could be inducibly deleted.
For this purpose, we utilized Ecdﬂ/ﬂ MEFs, which were previously established and shown
FIG 1 Legend (Continued)
(C), and then cell lysates were prepared at the indicated time points. Equal amounts of proteins were resolved by SDS-PAGE and then
subjected to Western blotting with the indicated antibodies. An increase in the level of p-eIF2 served as a marker for induction of ER stress.
(D to F) MCF-10A cells were treated with thapsigargin (D and E) and Panc-1 cells were cultured in glucose-free medium (F), and then total
RNA was isolated and subjected to qRT-PCR using CHOP primers and ECD primers. Data are means and standard deviations (SD) for 3
independent experiments *, P 0.05. CHOP mRNA induction served as a control for thapsigargin-induced ER stress. (G) Wild-type (WT) PERK
and PERK kinase domain knockout (PERK-KO) MEFs were treated with thapsigargin (50 nM) for 14 h, and then cell lysates were resolved in
SDS-PAGE gels and subjected to Western blotting with the indicated antibodies. (H and I) PERK-KO and control WT MEFs were treated with
thapsigargin, and total RNA was isolated at the indicated time points and subjected to qRT-PCR with primers targeting CHOP (H) or ECD (I).
(J) WT eIF2 MEFs or mutant eIF2 phosphodeﬁcient MEFs were treated with thapsigargin (Tg; 50 nM) or tunicamycin (Tun; 50 ng/ml) for
14 h, and then cell lysates were analyzed by Western blotting with the indicated antibodies.
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to exhibit Ecd gene deletion and loss of ECD protein expression upon infection with an
adenovirus expressing Cre recombinase (adeno-Cre) (41). Previously, we observed that
induction of Ecd deletion in these Ecdﬂ/ﬂ MEFs, aside from inducing cell cycle arrest, led
to a decrease in cell survival even in the absence of any stress (41, 42).
FIG 2 (Continued)
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Notably, Cre-mediated deletion of Ecd in the Ecdﬂ/ﬂ MEFs led to increases in the
levels of phospho-PERK (p-PERK) and p-eIF2 compared to those in control MEFs
infected with an adenovirus coding for green ﬂuorescent protein (adeno-GFP) (Fig. 3A,
compare lane 1 with lane 3), and these effects were further enhanced by treatment with
FIG 2 ECD colocalizes and associates with PERK and GRP78. (A to E) Immortal MEFs were ﬁxed in 3% paraformal-
dehyde (PFA), stained with the indicated antibodies, and mounted for analyses by structured illumination
microscopy (SIM). PERK and GRP78 colocalization served as a positive control. DAPI (4=,6-diamidino-2-phenylindole)
was used to stain the nucleus. (F) MCF-10A cells were fractionated into soluble and microsomal fractions. The purity
of the fractions was assessed by using GAPDH (a marker of the soluble/cytoplasmic fraction), PERK and SERCA (both
markers of the microsomal fraction), and RCAS1 (a Golgi-predominant protein) as markers (88). WCL, whole-cell
lysate. (G to J) MCF-10A cells were ﬁxed with 3% PFA and stained with the indicated antibodies (all antibodies were
generated in rabbits, except for the anti-ECD mouse antibody), followed by species-speciﬁc secondary antibodies
linked to cDNA probes to allow ﬂuorescent probe-based detection of the PCR ampliﬁcation products as distinct
foci. Incubation with proximity ligation assay plus and minus probes, followed by ligation and ampliﬁcation, was
carried out according to the manufacturer’s protocol. Red dots indicate interactions. ECD and PIH1D1 served as
positive controls. (K) Lysates of MCF-10A cells, treated with thapsigargin or left untreated, were subjected to IP with
anti-ECD antibody (left) or anti-GRP78 (right), followed by Western blotting with the indicated antibodies. ECD and
PIH1D1 (left) or GRP78 and PERK (right) served as positive controls.
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FIG 3 ECD regulates the PERK pathway of the UPR. (A and C) Ecdﬂ/ﬂ MEFs were infected with an
adenovirus coding for GFP (adeno-GFP; control) or Cre (adeno-Cre) for 72 h. The cells were then left
untreated or treated with thapsigargin (50 nM). Equal amounts of proteins were resolved in an SDS-PAGE gel
and then subjected to Western blotting with the indicated antibodies. (B) After adenovirus infection as
described for panel A, the cells were treated with thapsigargin. Total RNA was isolated and subjected to
qRT-PCR with CHOP primers. The data are means and SD for 3 independent experiments. *, P 0.05. (D) After
adenovirus infection as described for panel A, equal numbers (1,000) of wild-type (WT) or ECD/ cells were
plated in triplicate and treated with thapsigargin for 24 h. Ten days later, surviving colonies were assessed
after crystal blue (0.5% in 25% methanol) staining. The color retained after the wash was dissolved in 10%
acetic acid, and the absorbance at 590 nm was read. The graph in the bottom panel represents relative
absorbances. The data are means and SD for 4 independent experiments. *, P  0.05; **, P  0.002. UT,
untreated cells. (E) Panc-1 cells were treated with control or ECD siRNA for 48 h. The cells were then switched
to glucose-free medium, and cell lysates were prepared at the indicated time points and subjected toWestern
blotting with the indicated antibodies. (F, H, and I) ECD-inducible MEFs [Tet(O)-Flag- hECD-IRES-eGFP; rtTA] or
control MEFs [Tet(O)-Flag-hECD-IRES-eGFP] were treated with Dox for 48 h, followed by treatment with
thapsigargin (50 nM) or tunicamycin (50 ng/ml). Cell lysates were prepared at the indicated time points, and
equal amounts of proteins were resolved in an SDS-PAGE gel and subjected to Western blotting with the
indicated antibodies. (G) Following ECD induction and thapsigargin treatment as described above, CHOP
mRNA levels were assessed using qRT-PCR.
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thapsigargin, an inhibitor of the sarco-/endoplasmic reticulum calcium ATPase (Fig. 3A,
compare lane 2 with lane 4). Spliced XBP1 also showed some increase in ECD-null cells
upon thapsigargin treatment, while ATF6 did not show a signiﬁcant change (Fig. 3A).
Consistent with the increased p-PERK levels upon ECD deletion, thapsigargin-treated
ECD-depleted MEFs also exhibited increased expression of CHOP mRNA (Fig. 3B),
encoding a downstream effector of the PERK pathway whose target genes promote cell
death (24–28, 30, 31). The increased CHOP mRNA level correlated with an increased
level of cleaved caspase 3 in ECD-null cells (Fig. 3C, compare lane 2 with lane 4) and a
signiﬁcant reduction in cell survival as measured by colony formation assays (Fig. 3D).
To further assess these effects, we used physiological stress in Panc-1 cells (Fig. 3E)
subjected to ECD knockdown followed by glucose starvation. Again, small interfering
RNA (siRNA)-mediated knockdown of ECD plus glucose starvation led to enhanced
phosphorylation of eIF2, the downstream target of PERK, and increased cleaved
caspase 3 compared to that in control cells (Fig. 3E, compare lanes 1 to 5 with lanes 6
to 10), suggesting more cell death in ECD knockdown cells upon glucose starvation.
In a reciprocal approach, we overexpressed ECD and then examined its impact on
the UPR, in particular the PERK pathway, upon ER stress induction. To this end, we
generated MEFs from mice that carry a doxycycline (Dox)-inducible Ecd transgene
[Tet(O)-Flag-hECD-IRES-eGFP; rtTA] or a control transgenic mouse without rtTA [Tet(O)-
Flag-hECD-IRES-eGFP]. These MEFs were treated with Dox to induce ECD overexpres-
sion, followed by treatment with thapsigargin. As expected, control MEFs exhibited
increases in p-PERK and CHOP mRNA; however, the MEFs with Dox-induced ECD
overexpression exhibited substantially reduced levels of p-PERK and CHOP mRNA upon
thapsigargin treatment compared to those in control MEFs (Fig. 3F and G). Likewise,
when the MEF cell lines were treated with thapsigargin for various time points (3, 6, 12,
or 24 h), ECD-overexpressing MEFs exhibited lower levels of p-PERK than those in
control MEFs (Fig. 3H, compare lanes 1 to 5 with lanes 6 to 10). A corresponding
reduction in the levels of ATF4, a downstream target of PERK signaling, was seen in
ECD-overexpressing MEFs compared to control MEFs (Fig. 3H, compare lanes 3 to 5 with
lanes 8 to 10); s-XBP1 and ATF6 levels were also slightly reduced in ECD-overexpressing
MEFs (Fig. 3H, compare lanes 1 to 5 with lanes 6 to 10). Importantly, ECD overexpression
was associated with substantially higher levels of GRP78 following thapsigargin treat-
ment than those in control MEFs (Fig. 3H, compare lanes 2 to 5 with lanes 7 to 10); the
levels of GRP94 protein and PDI, two other chaperones, were also slightly increased in
ECD-overexpressing MEFs upon thapsigargin treatment, but not as dramatically as
those of GRP78 (Fig. 3H, compare lanes 1 to 5 with lanes 6 to 10). Similar to that with
thapsigargin, induction of ER stress with tunicamycin, which induces ER stress by
inhibiting glycosylation of proteins in the ER, was also associated with lower levels of
p-PERK and p-eIF2 in ECD-overexpressing MEFs than in control MEFs (Fig. 3I, compare
lanes 2 to 5 with lanes 7 to 10). Furthermore, higher levels of GRP78 protein were also
observed in ECD-overexpressing MEFs than in control MEFs upon tunicamycin treat-
ment (Fig. 3I, compare lanes 2 to 5 with lanes 7 to 10). Taken together, these results
strongly support the conclusion that ECD negatively regulates PERK signaling while
enhancing the adaptive capacity of cells by increasing the levels of chaperones,
predominantly the GRP78 protein, in response to ER stress.
Increased induction of GRP78 is required for ECD to attenuate PERK signaling.
Induction of GRP78 expression during ER stress is a homeostatic mechanism to reduce
the unfolded protein load in the ER, thereby reducing the activation of UPR sensors. As
a major regulator of PERK, overexpression of GRP78 has been shown to reduce PERK
signaling upon ER stress induction (13). Given the enhanced induction of GRP78
together with attenuation of PERK signaling in ECD-overexpressing MEFs exposed to ER
stress (Fig. 3H and I), we examined the possibility that the increased GRP78 levels upon
ECD overexpression are linked mechanistically to the reduction of PERK signaling. To
investigate this possibility, we ﬁrst examined changes in the levels of GRP78 in
ECD-deleted MEFs in which we observed increased PERK phosphorylation (Fig. 3A). To
assess if ECD was required for optimal GRP78 protein levels upon ER stress, we exposed
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wild-type MEFs or MEFs with an Ecd deletion induced by adeno-Cre (as for Fig. 3A to
D) to thapsigargin and then assessed the levels of GRP78 protein at various time points
by Western blotting. The levels of GRP78 over time were reduced in ECD-null MEFs
compared to the GRP78 levels in control MEFs (Fig. 4A, compare lanes 3 to 5 with lanes
8 to 10). Likewise, using physiological stress, knockdown of ECD in Panc-1 cells led to
a decrease in GRP78 levels upon glucose starvation (Fig. 4B, compare lanes 1 to 5 with
lanes 6 to 10). To examine whether the reduced induction of GRP78 in ECD-null MEFs
was a result of reduced GRP78 mRNA expression, we carried out quantitative PCR
(qPCR) analyses of mRNA isolated from WT or Ecd-null MEFs treated with thapsigargin.
As expected, GRP78 mRNA levels increased in WT MEFs upon thapsigargin treatment
(Fig. 4C); however, the levels of GRP78 mRNA induction in Ecd-null MEFs were compa-
rable to those in control MEFs (Fig. 4C). Similarly, GRP78 mRNA levels in control versus
ECD-overexpressing MEFs treated with thapsigargin were comparable (Fig. 4D). To
determine whether GRP78 may be less stable in Ecd-null cells, we ﬁrst knocked down
ECD in Panc-1 cells, which have high levels of GRP78, followed by inhibition of protein
synthesis by cycloheximide treatment for various times and analysis of GRP78 protein
levels by Western blotting. Signiﬁcantly, the time-dependent decrease in GRP78
protein levels following cycloheximide treatment was faster in ECD knockdown cells
than in control cells (Fig. 4E). Next, to examine the possibility that ECD overexpression
is associated with increased GRP78 protein stability, control or ECD-overexpressing cells
were treated with thapsigargin to induce the GRP78 protein, followed by cycloheximide
treatment for various times. Notably, the time-dependent decrease in GRP78 levels was
slower in ECD-overexpressing MEFs than in control MEFs (Fig. 4F). Finally, to determine
whether the increase in GRP78 protein levels upon ECD overexpression was required
for the attenuation of PERK activation seen upon ER stress induction, we depleted
GRP78 by use of siRNA in both control and ECD-overexpressing MEFs, followed by
thapsigargin treatment. Notably, the attenuating effect of ECD overexpression on PERK
phosphorylation upon thapsigargin treatment was abrogated by GRP78 knockdown
(Fig. 4G, compare lanes 5 and 6 with lanes 7 and 8). Taken together, these results
support the conclusion that ECD positively regulates the GRP78 protein level upon ER
stress induction to attenuate PERK activation.
ECD overexpression protects cells from ER stress-induced cell death. The ER
stress response is initially aimed at the survival of cells (62); however, severe ER
stress shifts the response from a prosurvival to a proapoptotic response (23, 31)
through PERK-mediated induction of expression of CHOP, a transcription factor that
enhances the expression of proapoptotic pathway genes (24–28, 30, 31, 63). Several
studies found that inhibition/attenuation of the PERK pathway protected cells
against stress-induced cell death (64–67). Given our observation that ECD functions
as a modulator of PERK signaling, we assessed if the level of ECD determines a
differential survival versus apoptotic cell fate upon ER stress induction. For that
purpose, we treated control MEFs or Dox-inducible ECD-overexpressing MEFs with
thapsigargin and then assessed the level of apoptosis induction by examining
caspase 3 cleavage (68). As anticipated, a thapsigargin dose-dependent increase in
cleaved caspase 3 levels was observed in control MEFs, whereas the levels of
cleaved caspase 3 were markedly lower in ECD-overexpressing MEFs (Fig. 5A).
Real-time qPCR analyses demonstrated that thapsigargin-induced expression of
CHOP, a PERK-regulated mediator of cell death (24–28, 30–32), was lower in
ECD-overexpressing MEFs than in control MEFs (Fig. 5B). To further assess the
prosurvival effects of ECD against an apoptotic cell fate upon ER stress induction,
we assessed the abilities of control versus ECD-overexpressing MEFs to form
colonies after their exposure to ER stress. For this purpose, equal numbers of
control and ECD-overexpressing MEFs were treated with thapsigargin for 24 h, and
the cells were then maintained in thapsigargin-free medium for 10 days, followed
by crystal violet staining and counting of surviving colonies. Notably, more colonies
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FIG 4 Increased induction of GRP78 expression is required for ECD to downregulate PERK signaling. (A) Ecdﬂ/ﬂ MEFs were treated with
adenovirus as described in the legend to Fig. 3A to C, and then the cells were treated with thapsigargin (50 nM). Cell lysates were prepared
(Continued on next page)
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were observed for ECD-overexpressing MEFs than for control MEFs (Fig. 5C), further
supporting the conclusion that ECD provides a survival advantage upon ER stress.
DISCUSSION
The ER-localized stress response pathway referred to as the UPR is a well-conserved
response to a number of cellular stresses, such as unfolding of proteins in the ER. The
UPR elicits a spectrum of downstream responses whose outcomes range from resto-
ration of homeostasis to cellular apoptosis if the stress is extreme and prolonged (23,
31). The UPR thus represents a double-edged sword and must be intricately regulated
to prevent inappropriate cellular outcomes. Mechanisms that help to modulate the
magnitude and type of UPR in response to physiological or pathological stress stimuli
are not fully understood. In this study, we provide evidence that the ECD protein is a
negative regulator of the PERK arm of the UPR through GRP78.
Several lines of circumstantial evidence, discussed in the introduction, suggested a
potential involvement of ECD in the UPR, but direct support for such a role has been
lacking. We established that induction of ER stress by use of both chemical ER stress
inducers (thapsigargin and tunicamycin) and a physiological ER stressor (glucose
starvation) leads to downregulation of ECD protein levels, while the mRNA levels are
elevated (Fig. 1A to F). By using PERK-KO or phosphorylation-deﬁcient eIF2 MEFs (Fig.
1G to J), we established that ECD is linked to the PERK pathway of the UPR. The
association of ECD with PERK and GRP78 (Fig. 2) further linked ECD to the PERK arm of
the UPR. A functional connection of ECD to the PERK arm of the UPR is supported by
the distinct modulation of the PERK-mediated responses elicited by perturbations
of the cellular levels of ECD. Depletion of ECD sensitized cells to PERK signaling in
response to ER stress, with increases in p-PERK and p-eIF2 levels as well as an increase
in the downstream effector of PERK, the transcription factor CHOP, leading to reduced
survival of these ECD-depleted MEFs (Fig. 3A to E). Reciprocally, upregulation of ECD
reduced PERK signaling upon induction of ER stress (Fig. 3F to I). As activation of the
PERK pathway promotes cell death in response to ER stress, primarily through CHOP-
dependent expression of proapoptotic genes (24–32), and inhibition/attenuation of
PERK signaling protects cells against stress-induced cell death (64–66), our results
support the likelihood that ECD functions to modulate PERK pathway activity and
promote cell survival during ER stress. Indeed, assessment of cellular survival in
response to ER stress showed that reductions in ECD levels impaired cell survival in
response to ER stress (Fig. 3C to E), while overexpression of ECD promoted cell survival
(Fig. 5). Collectively, these results support the conclusion that ECD and PERK are linked
through a negative-feedback mechanism whereby ECD exerts an inhibitory effect on
PERK pathway signaling, whereas activated PERK reduces ECD protein levels via eIF2-
dependent translational blocking. Consistent with a reciprocal negative-feedback rela-
tionship between ECD and PERK, activated PERK negatively regulates cell growth
(33–35); conversely, ECD positively regulates cell growth (41) and is overexpressed in
human breast and pancreatic cancer specimens, correlating with poor prognostic
markers and shorter survival times (69, 70). While the physiological beneﬁt of increased
ECD mRNA upon ER stress is not yet understood, we speculate that this effect may
FIG 4 Legend (Continued)
at the indicated time points. Equal amounts of proteins were resolved in an SDS-PAGE gel and then subjected to Western blotting with
the indicated antibodies. (B) ECD was knocked down by use of siRNA (20 nM) in Panc-1 cells, followed by exposure to glucose-free
medium, and cell lysates were collected at the indicated time points and subjected to Western blotting with the indicated antibodies. (C
and D) Following ECD deletion (C) or ECD overexpression (D) and thapsigargin treatment as described above, the levels of GRP78 mRNA
were assessed in WT (control) versus ECD/ (adeno-Cre treated) or control versus ECD-overexpressing MEFs by use of qRT-PCR. (E) ECD
was knocked down in Panc-1 cells, followed by cycloheximide treatment (25 M). Cell lysates were prepared at the indicated time points
and subjected to Western blotting with the indicated antibodies. (F) ECD-inducible MEFs and their control MEFs were treated with Dox
as described previously, followed by treatment with thapsigargin and then cycloheximide treatment (25 M) for the indicated times. Cell
lysates were prepared and subjected to Western blotting with the indicated antibodies. (G) ECD-overexpressing MEFs and control MEFs
were treated with GRP78 siRNA (30 nM) or control siRNA (scrambled). Twenty-four hours later, the cells were treated with Dox for 48 h
to induce ECD overexpression, followed by thapsigargin treatment (50 nM). Equal amounts of proteins were resolved in an SDS-PAGE gel
and subjected to Western blotting with the indicated antibodies.
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FIG 5 ECD overexpression provides a survival advantage. (A) ECD was induced as described in the
legends to Fig. 3 and 4, followed by thapsigargin treatment for 24 h. Equal amounts of proteins were
resolved in an SDS-PAGE gel and then subjected to Western blotting with the indicated antibodies. (B)
Following ECD induction with Dox and thapsigargin treatment as described above, total RNA was
isolated, and CHOP mRNA was assessed by qPCR. The data are means and SD for 3 independent
(Continued on next page)
Olou et al. Molecular and Cellular Biology
September 2017 Volume 37 Issue 18 e00030-17 mcb.asm.org 14
 o
n
 August 29, 2017 by W








reﬂect a feedback response to the decrease in ECD protein levels to compensate for the
loss of ECD, but ECD translation is blocked. Although ECD has been reported to play
roles in pre-mRNA splicing in Drosophila (71), it is unlikely that ECD alters its own mRNA
splicing upon ER stress, because ECD protein levels decrease upon ER stress.
Modulation of ECD levels by knockdown or overexpression demonstrated that
ECD is a positive regulator of GRP78 levels (Fig. 3H and I and 4). While slight
increases in GRP94 and PDI levels were observed, the effect on GRP78 was more
dramatic. As increased expression of GRP78 and other chaperones is known to
promote clearing of the ER stress-causing unfolded protein load and to reduce the
activation of UPR sensors (13–15, 55), we surmise that upregulation of GRP78 and
other chaperones (Fig. 3H) may represent one potential mechanism by which ECD
negatively regulates PERK pathway activation and relieves ER stress. Indeed, knock-
down of GRP78 eliminated the ability of overexpressed ECD to attenuate PERK
pathway signaling (Fig. 4G). Notably, GRP78 is required for cell survival not only in
response to ER stress (72–75) but also under other stressful and hostile conditions,
such as glucose deﬁciency encountered in the tumor microenvironments (76–81).
Given that the PERK arm of the UPR is also activated in cancer (63, 82, 83) and that
both ECD and GRP78 are overexpressed in cancer (69, 70, 76–81), we suggest that
ECD overexpression may play a similar role to mitigate the negative consequences
of elevated PERK signaling found in cancer. Given the mechanistic link between ECD
and GRP78 in inhibiting the PERK pathway to promote cell survival, it would be of
great interest to explore if GRP78 and ECD are cooverexpressed in tumors that use
the UPR to promote tumor cell survival and hence may be suitable targets for
UPR-directed therapeutic agents.
MATERIALS AND METHODS
Reagents and antibodies. Thapsigargin and tunicamycin were obtained from Cell Signaling, dissolved
in dimethyl sulfoxide (DMSO), and used at the indicated concentrations. siRNA against GRP78 was from Santa
Cruz, and cycloheximide was purchased from Sigma. A monoclonal antibody against ECD, generated in our
laboratory, has been described previously (69). Antibodies against p-PERK, ATF4, p-eIF2, eIF2, GRP78,
caspase 3, GRP94, s-XBP1, RCAS1, PDI, and total PERK were from Cell Signaling. ATF6 and SERCA2 antibodies
were purchased from Enzo Life and Abcam, respectively. PERK and GRP78 used for immunoﬂuorescence and
proximity ligation assay (PLA) were obtained from Santa Cruz and Abcam, respectively. PIH1D1 was from
Santa Cruz (18Y9). GRP78 for IP and Western blotting was purchased from Abcam.
Establishment of MEFs with doxycycline-inducible ECD overexpression from Ecd-transgenic
mice. MEFs were generated from 13.5-day-old embryos of mice of the Tet(O)-Flag-hEcd-IRES-eGFP
genotype, used as a control. rtTA was introduced retrovirally to generate Tet(O)-Flag-hEcd-IRES-eGFP;
rtTA mice (the derivation of the transgenic mice will be described in a separate report). The mice were
handled in accordance with the Institutional Animal Care and Use Committee (IACUC).
Cell lines and culture conditions. Ecdﬂ/ﬂMEFs weremaintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum and treated with an adenovirus coding for GFP
(adeno-GFP; control) or Cre (adeno-Cre), as described previously (41, 42). Panc-1 cells have been described
previously (84). For ECD overexpression studies, control MEFs or ECD-overexpressing MEFs were cultured with
1 g/ml of doxycycline (BD Biosciences) to induce expression of the Ecd transgene. MEFs with nonphosphor-
ylatable eIF2 were obtained from the lab of Thomas Rutkowski, Carver College of Medicine, IA, and have
been described elsewhere (59). PERK knockout (PERK-KO) MEFs were from ATCC (CRL-2976). The immortal
human mammary epithelial cell line MCF-10A was cultured in DFCI-1 medium (42).
Cellular fractionation and immunoprecipitation. Subcellular fractionation of MCF-10A cells into
soluble (glyceraldehyde-3-phosphate dehydrogenase [GAPDH] was used as amarker [42, 85]) andmicrosomal
(PERK and SERCA2 were used as markers) fractions was carried out according to the manufacturer’s protocol
(Sigma-Aldrich) (86). For immunoprecipitation (IP), cells were washed in phosphate-buffered saline (PBS) and
lysed in CHAPS buffer {0.3% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 20 mM
Tris-HCl (pH 7.4), 120 mM NaCl, 10% glycerol, 5 mM EDTA supplemented with protease and phosphatase
inhibitors (Roche)}.
FIG 5 Legend (Continued)
experiments. *, P  0.05. (C) After ECD induction, control and ECD-inducible MEFs were trypsinized, and
equal numbers of cells (1,000) were plated in triplicate. Eight hours later, the cells were treated with
thapsigargin for 24 h. Ten days later, surviving colonies were assessed by crystal blue staining (0.5% in
25% methanol). The color retained after the wash was dissolved in 10% acetic acid, and the absorbance
at 590 nm was read. The graph at bottom represents relative absorbances. The data are means and SD
for 4 independent experiments. **, P  0.002.
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Western blotting. For Western blotting, cell lysates were prepared in radioimmunoprecipitation
assay (RIPA) buffer (Thermo Scientiﬁc) supplemented with protease inhibitors (Roche). Lysates were
resolved in an SDS-PAGE gel, transferred onto a nylon membrane (IPVH00010; Millipore), and subjected
to enhanced chemiluminescence (ECL)-based Western blotting as described previously (41, 42).
Immunoﬂuorescence analysis. Immortal MEFs were cultured on coverslips, ﬁxed for 30 min in 3%
paraformaldehyde (PFA), and permeabilized in PBS (containing 0.5% Triton X-100 and 10% goat serum)
for 20 min at room temperature, followed by blocking in PBS (containing 10% goat serum) for 1 h at
room temperature. The cells were then incubated with primary antibodies in blocking buffer overnight
at 4°C, followed by a 1-h incubation with the corresponding secondary antibodies in blocking buffer at
room temperature. Cells were then washed in PBS (containing 0.1% Tween 20) and mounted for confocal
microscopy and superresolution structured illumination microscopy (SIM). Confocal images were ob-
tained using a Carl Zeiss LSM 510 microscope, and three-dimensional (3D) SIM images were collected
with an ELYRA PS.1 illumination system (Carl Zeiss).
PLA. PLA was performed as previously described (87). Brieﬂy, MCF-10A cells were ﬁxed with 3% PFA,
stained with the indicated antibodies, and incubated with proximity ligation assay plus and minus
probes, followed by ligation and ampliﬁcation reactions according to the manufacturer’s protocol
(DuoLink; Sigma).
Colony formation assay. For clonogenic assay, 1,000 cells were plated in triplicate and allowed to
attach to the plate (about 8 h), followed by treatment with thapsigargin for 24 h. Ten days later, colony
formation was assessed as previously described (41, 42).
RNA isolation and qRT-PCR. Total RNA was isolated using Trizol reagent (Invitrogen). One micro-
gram of RNA was reverse transcribed by use of SuperScript II reverse transcriptase (Invitrogen). qPCR was
performed with the primer sets indicated in Table 1.
Induction of ER stress by glucose starvation. Panc-1 cells were maintained in DMEM supple-
mented with 10% fetal bovine serum and then switched to glucose-free DMEM (Life Technologies) for
the indicated times.
Statistical analysis. For assessment of statistical signiﬁcance, the Student t test was used. P values
of 0.05 were considered statistically signiﬁcant.
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